David Pariser
Overview
Explore the profile of David Pariser including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
1482
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pariser D, Glaser D, Del Rosso J, Bhatia N, Hooper D, Nestor M, et al.
J Am Acad Dermatol
. 2025 Mar;
PMID: 40054501
Background: Current treatments for primary axillary hyperhidrosis are insufficient for some patients. Sofpironium topical gel is a retrometabolically-designed topical anticholinergic with rapid metabolism, which is associated with reduced side effects...
2.
Coleman W, Bertucci V, Humphrey S, Kaufman-Janette J, Keaney T, Pariser D, et al.
Aesthet Surg J
. 2024 Nov;
PMID: 39587780
Background: Botulinum neurotoxins used in aesthetic medicine require reconstitution before administration, which may be inconvenient and present errors among injectors. Objectives: Evaluate the efficacy and safety of ready-to-use nivobotulinumtoxinA liquid...
3.
Zouboulis C, Passeron T, Pariser D, Wozniak M, Li X, Uhlmann L, et al.
Br J Dermatol
. 2024 Mar;
190(6):836-845.
PMID: 38470171
Background: Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease associated with a substantial disease burden. Secukinumab has previously been reported to have sustained efficacy with a favourable safety profile...
4.
Integrating Precision Medicine into Medical Dermatology Clinical Practice: An Expert Consensus Panel
Zakria D, Brownstone N, Armstrong A, Boh E, Koo J, Merola J, et al.
J Drugs Dermatol
. 2023 Jun;
22(6):588-593.
PMID: 37276166
Background: Precision medicine utilizes an individual’s genomics to improve diagnosis, prognosis, and therapy. The joint American Academy of Dermatology and National Psoriasis Foundation 2019 guidelines recognized the need to identify...
5.
Saal R, Oldfield C, Bota J, Pariser R, Pariser D
J Drugs Dermatol
. 2023 Apr;
22(4):339-343.
PMID: 37026885
Background: Hailey-Hailey disease (HHD) can be treated with topical steroids, antibiotics, and invasive surgical procedures. Since sweating often exacerbates HHD lesions, the use of onabotulinumtoxin A could serve as an...
6.
Nestor M, Pariser D, Del Rosso J, Glaser D, Goldberg D, Ablon G, et al.
J Clin Aesthet Dermatol
. 2023 Jan;
15(12 Suppl 1):S28-S31.
PMID: 36588785
Objective: Dermatology and aesthetic medicine has experienced significant growth in recent years, driven by industry-sponsored research performed by clinical investigators. Contract research organizations (CROs) play an important role to ensure...
7.
Nestor M, Pariser D, Del Rosso J, Glaser D, Goldberg D, Ablon G, et al.
J Clin Aesthet Dermatol
. 2022 Oct;
15(9):16-19.
PMID: 36213607
Objective: Dermatology and aesthetic medicine has experienced significant growth in recent years, driven by industry-sponsored research performed by clinical investigators. Contract research organizations (CROs) play an important role to ensure...
8.
Kim E, Mangold A, DeSimone J, Wong H, Seminario-Vidal L, Guitart J, et al.
JAMA Dermatol
. 2022 Jul;
158(9):1031-1039.
PMID: 35857290
Importance: Given that mycosis fungoides-cutaneous T-cell lymphoma (MF/CTCL) is chronic, there is a need for additional therapies with minimal short- and long-term adverse effects. Topical synthetic hypericin ointment, 0.25%, activated...
9.
Strober B, Fox J, Jekowsky E, Pariser D, Schaecher K
J Drugs Dermatol
. 2022 Jun;
21(6):630-636.
PMID: 35674756
Precision medicine approaches are receiving increased attention in dermatology, including inflammatory skin diseases. In psoriasis, a precision medicine treatment paradigm could temper the rapid increase in pharmacy costs that have...
10.
Pariser D, Rivera E, Benedict D
J Drugs Dermatol
. 2022 May;
21(5):488-495.
PMID: 35533035
Background: Hyperhidrosis of the palms has a significant negative impact on quality of life. There is no FDA-approved treatment; however, clinicians often use glycopyrronium cloth off-label for this indication despite...